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Abstract 
Objectives:  Results from previous studies have been inconsistent on the association between 
selenium and hypertension, and very few studies on this subject have focused on the elderly 
population. The purpose of this study is to examine the relationship between selenium level and 
hypertension in a rural elderly Chinese cohort.  
Design: A longitudinal study was implemented and data were analyzed using logistic regression 
models and Cox proportional hazards regression model adjusting for potential confounders. The 
association between selenium level and prevalent hypertension at baseline and between selenium 
and incident hypertension were examined. 
Setting: Community-based setting in four rural areas in China. 
Subjects: A total of 2000 elderly aged 65 years and over (mean 71.9±5.6 years) participated in 
this study. 
Measurements: Nail selenium levels were measured in all subjects at baseline. Blood pressure 
measures and self-reported hypertension history were collected at baseline, 2.5 years and 7 years 
later.  Hypertension was defined as systolic blood pressure 140 mmHg or higher, diastolic blood 
pressure 90 mmHg or higher, or reported use of anti-hypertensive medication.  
Results:  The rate of baseline hypertension was 63.50% in this cohort and the mean nail 
selenium level is 0.413±0.183μg/g. Multi-covariate adjusted cross-sectional analyses indicated 
that higher selenium level was associated with higher blood pressure measures at baseline and 
higher rates of hypertension. For the 635 participants with normal blood pressure at baseline, 360 
had developed hypertension during follow-up. The incidence rate for hypertension was 45.83%, 
52.27, 62.50%, 70.48%, and 62.79% from the first selenium quintile to the fifth quintile 
respectively. Comparing to the lowest quintile group, the hazard ratio were 1.41 (95%CI: 1.03 
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to1.94), 1.93 (95%CI: 1.40 to 2.67), 2.35 (95%CI: 1.69 to 3.26) and 1.94 (95%CI: 1.36 to 22.77) 
for the second selenium quintile to the fifth quintile respectively.  
Conclusions:  Our findings suggest that high selenium may play a harmful role in the 
development of hypertension. Future studies are needed to confirm our findings and to elucidate 
a plausible biological mechanism. 
Keywords:  Selenium; Hypertension; Blood pressure; Elderly population; Environmental 
exposure 
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Introduction 
Hypertension affects nearly one billion people worldwide, many of them over the age of 65, and 
contributes to the global burden of disease and mortality [1]. Studies have shown that oxidative 
stress is one of the fundamental mechanisms underlying hypertension [2]. Antioxidants inhibit 
oxidation reactions, thereby reducing the number of free radicals produced and the amount of 
damage they can cause. Selenium, an essential trace element with antioxidant properties [3], was 
hypothesized to have a protective effect on hypertension [4].  
A link between selenium and hypertension was provided in selenium’s role in Keshan disease, a 
disorder that occurred in regions of China where selenium was severely deficient in the soil and 
diet, the symptoms of Keshan disease, including hypertension, can be relieved by administering 
selenium supplements [5]. There are reports from observational studies of higher selenium levels 
associated with lower blood pressure [6-8].  However, other studies have shown that in 
populations where selenium levels exceed the recommended daily intake, higher selenium levels 
were found to be associated with higher blood pressure and higher rates of hypertension [9-11]. 
It should be noted that few of published studies are longitudinal in design. In addition to the 
inconsistency in findings on the relationship between selenium and blood pressure, very few 
studies on this subject have focused on the elderly population despite the considerable proportion 
of the elderly suffering from hypertension.  The objective of this study was to examine the 
relationship between selenium level and hypertension in an elderly Chinese population.   
Materials and methods 
Study design and participants 
Participants were recruited for the Selenium and Cognitive Decline study, a longitudinal 
epidemiologic project funded by the National Institute of Health examining the long-term impact 
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of selenium on cognitive decline in rural elderly Chinese. Participants were enrolled between 
2003 and 2005, and underwent two follow-up evaluations at 2.5 years and 7 years after baseline. 
Two counties from Sichuan Province in southwestern China, and two counties from Shandong 
Province in eastern China were selected for the project. These study sites were selected for the 
following reasons: (1). They were rural counties; (2). The two counties within a province 
differed in selenium levels but were similar in demographics and other trace element measures; 
and (3). The four counties were also required to have sufficient population so that the local 
elderly population was large enough to provide a sample of 500 elderly subjects. Sites with 
known endemic diseases (including Keshan disease, Kaschin-Beck disease, goiter and Cretinism, 
and fluorosis) were excluded from consideration.  Details on site selection process were 
described previously [12].  
Residents aged 65 years or older from these four counties were invited to participate in the study. 
The only exclusion criterion is severe hearing loss which makes it impossible to conduct 
cognitive assessment. For each county included in the study, interviews were conducted from 
village to village, and completed when 500 elderly participants were enrolled. The total sample 
size was 2000 at baseline, 95 participants were lost during the 2.5 year follow-up because of 
death. The study was approved by Indiana University Institutional Review Board and the 
Institute for Environmental Health and Related Safety, Chinese Center for Disease Control and 
Prevention.  
Hypertension and Blood Pressure Measurements 
During the interview, participants were asked whether they were ever told by a doctor or a health 
care professional that they had hypertension or high blood pressure defined as systolic blood 
pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg.  A follow-up question of 
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whether they were taking any anti-hypertensive medications was asked if they answered “yes” to 
the hypertension question.   
A physical examination was also conducted during the interview.  Two consecutive 
measurements of systolic and diastolic blood pressure were taken by trained interviewers using a 
mercury sphygmomanometer while the participant was seated following the protocol outlined in 
the Hypertension Detection and Follow-up Program and used in other studies [13]. The average 
of the two blood pressure measurements was used in all analyses. The hypertension and blood 
pressure measures were collected at baseline, 2.5 and 7 years after baseline. In this analysis, 
hypertension was defined as systolic blood pressure 140 mmHg or higher, diastolic blood 
pressure 90 mmHg or higher, or reported use of anti-hypertensive medication. 
Selenium Measures  
Nail samples were collected at the time of interview and stored in clean plastic bags during the 
baseline survey. Fluorometric determination of trace amount of selenium with 2, 3-
diaminonaphthalene was used to determine trace amounts of selenium in nails. The details on 
laboratory procedures and quality control measures were described elsewhere [12].    
Covariates  
Other information collected during the survey included age, gender, education (whether the 
participant had attended school), alcohol consumption and smoking history. Participants’ height 
and weight were also measured during the interview. Body Mass Index (BMI, defined as body 
weight in kilograms divided by height in meters squared) was derived from height and weight 
measurements. The International Physical Activity Questionnaire (IPAQ) was added during the 
2.5-year and 7-year follow-up survey. Physical activity was classified into the three categories of 
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low, moderate and high according to the Guidelines for Data Processing and Analysis of the 
IPAQ [14]. 
Statistical analysis  
To capture potential non-linear relationships between selenium levels and blood pressure 
measures, the study population was divided into quintiles according to nail selenium levels. In 
addition to selenium levels, we considered the following variables potential confounding factors 
possibly related to both blood pressure and selenium levels: age, gender, education, BMI, 
smoking, alcohol  consumption and IPAQ.  
Analysis of variance (ANOVA) was used to compare the means of continuous variables and chi-
square test was used to compare proportions of categorical variables across selenium quintile 
groups. Analysis of covariance (ANCOVA) models were used to determine the association 
between selenium level and baseline blood pressure adjusting for other covariates.  Logistic 
regression models were used to determine the association between selenium levels and baseline 
hypertension adjusting for the aforementioned confounders.  
Participants who were normotensive at baseline were included in the longitudinal analysis. The 
incidence rates of hypertension were compared among the five selenium quintile groups using 
chi-square test. Time to incident hypertension during the 7-year follow-up was used as the 
outcome variable in Cox proportional hazards regression models to examine the effect of 
baseline selenium level on the incidence of hypertension. Participants who remained 
normotensive were censored at the last evaluation.  
All analyses were performed using SAS9.1 for Windows (SAS Institute Inc., Cary, North 
Carolina, USA). P<0.05 was considered statistically significant. 
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Results 
For the baseline sample of 2000 participants, mean age was 71.9±5.6 and mean nail selenium 
level is 0.413±0.183μg/g. Among the five nail selenium quintile groups significant differences 
were seen on gender, education, alcohol consumption, smoking, BMI，systolic blood pressure, 
diastolic blood pressure and hypertension rate, while no difference in age was observed, as 
shown in Table 1. The rate of hypertension was 63.50% for the total population at baseline. 
Hypertension rates at baseline ranged from 43.78%, 62.22%, 66.33%, 69.52%, to 75.81% with 
the increasing order of selenium level in the selenium quintile groups respectively (Figure 1). 
Univariate analysis indicated that the males, smokers and alcohol consumers had significantly 
lower selenium level compared with the females, non-smokers and non-alcohol consumers, 
respectively and that selenium was positively associated with BMI (P<0.05 for all comparisons. 
Results not shown).  Selenium level in participants with hypertension was significantly higher 
than in the normotensive, with mean selenium levels 0.442±0.181μg/g and 0.364±0.175μg/g in 
the hypertensive and normotensive participants, respectively.  
In Table 2, we present results on the association between selenium quintiles and baseline 
hypertension or blood pressure adjusting for various covariates. Parameter estimates from the 
ANCOVA models are the estimated differences in mean blood pressure measures between each 
selenium quintile group and the reference group while adjusting for other covariates. Comparing 
to participants in the lowest selenium quintile group, those in the four other quintile groups had 
significantly higher systolic blood pressure and diastolic blood pressure. Higher baseline 
selenium is also significantly associated with hypertension with odds ratios of 2.17(95%CI: 1.63 
to 2.90), 2.46(95%CI: 1.83 to 3.23), 2.72(95%CI: 2.00 to 3.70), 3.55 (95%CI: 2.59 to 4.87) from 
the second selenium quintile to the fifth quintile, respectively. There are no differences on 
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hypertension rates among the four top quintile groups since the confidence intervals of the odds 
ratio estimates overlap.  
In the 730 participants with normal blood pressure at baseline, 635 participated in the follow-up 
evaluations (95 had died), 360 had developed incident hypertension. Baseline population 
characteristics did not differ between those with incident hypertension and the normotensive with 
respect to age, gender, education, alcohol consumption, smoking and diastolic blood pressure 
(Table 3). However, selenium level, BMI and systolic blood pressure were significantly higher in 
those with incident hypertension than in the normotensive. 
Crude incidence rates for hypertension were 45.83%, 52.27, 62.50%, 70.48%, 62.79% from the 
first quintile to the fifth selenium quintile groups, respectively (Figure 2). In Table 4, we present 
results of the Cox model that baseline selenium level was significantly associated with the 
incidence of hypertension adjusting for other covariates. Comparing to the lowest selenium 
quintile group, hazard ratios for incident hypertension were 1.41 (95%CI: 1.03 to1.94), 1.93 
(95%CI: 1.40 to 2.67), 2.35 (95%CI: 1.69 to 3.26) and 1.94 (95%CI: 1.36 to 22.77) for the 
second selenium quintile to the fifth selenium quintile groups, respectively.  
Discussion 
In this study, we examined the associations between selenium level and hypertension in a 7-year 
follow up of elderly Chinese population in the Selenium and Cognitive Decline study. We found 
that participants with higher selenium levels had higher blood pressure and hypertension rate at 
baseline, and participants with higher baseline selenium levels also had greater risk of 
developing hypertension. 
There were four published longitudinal studies focusing on the association between selenium and 
blood pressure or hypertension [8, 15-17]. In a prospective study in Belgium [8], a significant 
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protective effect of selenium on incident hypertension was observed in young adult males, but no 
significant relationship was observed in females. The other three studies reported non-significant 
associations between selenium and hypertension [15-17]. A previous systematic literature review 
published in 2014 found no conclusive evidence supporting an association between selenium 
levels and hypertension [18]. Our findings are consistent with results from several cross-
sectional studies and case-control studies. In the US National Health and Nutrition Examination 
Survey data (2003–2004), high serum selenium concentrations were associated with higher 
prevalence of hypertension [10]. Another cross-sectional study in 3387 males aged 53-74 years 
also found an association between higher selenium levels and higher hypertension rates [11].  
Similar result was also reported in a case-control study in France [9]. However, there were 
studies reporting non-significant association [19-21] while others supported an inverse 
association between selenium levels and hypertension [6, 22, 23]. In a cross-sectional study on 
722 males with mean age 54 years old in eastern Finland higher selenium level was found to be 
associated with lower hypertension rate [6]. Two case-control studies reported lower selenium in 
hypertensive patients than in normal controls [22, 23]. In addition to observational studies, 
randomized controlled trials with selenium as one of the intervention agents also reported 
protective effect on hypertension [24, 25].  
The inconsistent results from previous studies may be partially due to the difference in selenium 
exposure levels among the different study populations. In most previous studies, selenium’s 
harmful effect on hypertension was more likely to be seen in selenium-replete populations and 
protective effect seen in selenium-deplete populations [18]. Moreover, the definition of 
hypertension varied among different countries, such as Belgium [8], Denmark [11], Finland [26 ], 
and the United States [17]. Other factors contributing to the inconsistent results include 
11 
 
differences in study design, adjustment for confounding factors and the difference in the age 
range covered by a study.  While the biological mechanism underlying a positive association 
between selenium and blood pressure measure is not yet fully understood, selenium’s effect on 
oxidative stress has been investigated in animal studies. As a key component of many 
antioxidant enzymes, such as glutathione peroxidase (GPx) selenium plays an important role in 
oxidative stress [27], which is recognized as one of the fundamental mechanisms underlying 
hypertension [2]. An experimental study had observed that selenium at low doses can provide 
significant protection of the human coronary artery endothelium against damage by oxidative 
stress [28]. In an animal model, dietary supplementation with selenium was associated with 
lower levels of cardiac oxidative damage and increased antioxidant expression, as well as a 
reduction in disease severity and mortality in spontaneously hypertensive rats [29]. Although 
experimental results mentioned above support the hypothesis that selenium deficiency is 
associated with oxidative stress, nonlinear dose-response relationship between selenium 
exposure and oxidative stress biomarkers was observed in a recent study suggesting that high 
selenium levels increase oxidative stress [30]. Our study, unfortunately, did not have measures of 
other oxidative stress markers and will not be able to examine the role of oxidative stress in the 
association between selenium and hypertension. More future studies on the relationship among 
selenium level, oxidative stress and hypertension are needed.  
Thus far, most studies examining the relationship between selenium and hypertension have either 
included subjects over a very broad age range or have focused on middle-aged adults or children.  
Our study focused exclusively on the elderly population where hypertension is much more 
prevalent. Enrolling participants from rural areas also ensured that the majority of the 
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participants in our study had lived in the same village their entire lives and they were not taking 
dietary supplements, thus providing a stable, long-term measure of selenium exposure.  
It is important to note that nail selenium represents a more stable measure of long-term exposure 
to selenium [31] and selenium level in nails does not fluctuate greatly with daily selenium intake 
in the diet [32]. In a previous study in the same cohort [12], we have confirmed that selenium 
levels in nail samples were significantly correlated with selenium levels measured in blood and 
dietary intake derived from food frequency questionnaire. Although we are unable to compare 
selenium levels in our study directly with selenium levels measured in blood or hair samples in 
other studies, the selenium level in our cohort was similar to the Finland study of age 55-69 year 
old sample [32], and lower than toenail selenium levels in the American [11,33] and the 
Northern Italy samples [34].  
Strengths and limitations 
Our study has a number of strengths. The first is the prospective study design and the relatively 
large sample size ensuring adequate statistical power. The second is the relatively low selenium 
level in the study population without selenium supplementation, providing an opportunity to 
explore the associations between selenium exposure and hypertension. The third is the selenium 
measurements in nail samples, which provided a relatively long-term measure of exposure 
compared with selenium measured in blood or urine samples. 
There are also several limitations in this study. The first is that the cohort included participants 
older than 65 years of age. Therefore, it is not known whether the observed association between 
selenium and hypertension holds in populations of younger subjects. Another limitation was that 
glutathione peroxidase (GPx) activity was not measured.  Measuring GPx levels may enable us 
to compare enzyme activity to selenium levels and gain a better understanding of the association 
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between selenium and hypertension.  Finally, the current study did not consider genetic factors or 
other environmental factors that may influence or modify the association between selenium level 
and the risk of hypertension.  
Conclusions: Our results, both cross-sectional and longitudinal, suggest that higher selenium 
may be associated with the risk of hypertension. Future studies in other populations of similar or 
different age composition are needed to confirm our findings. In addition, studies that 
incorporate more biomarkers are needed to elucidate the biological mechanism underlying the 
association between selenium and hypertension.   
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Table 1: Baseline characteristics of participants by nail selenium quintile groups. 
Characteristics Total (n=2000) 
Quintile groups of selenium level in nail samples (μg/g) 
P Value Q1(n=402) Q2 (n=405) Q3 (n=395) Q4(n=397) Q5(n=401) 
(≤0.233) (0.234-0.362) (0.363-0.442) (0.443-0.552) (>0.552) 
Nail selenium, 
(μg/g) 
0.413±0.18
3 0.187±0.030 0.302±0.038 0.407±0.022 0.492±0.032 0.683±0.143 <0.0001 
Age (years) 71.9±5.6 72.0±5.6 72.2±5.6 71.9±5.5 71.8±5.4 71.6±5.7 0.6858 
Female (%) 53.7 52.0 45.2 47.1 59.2 64.8 <0.0001 
Attended school（
%） 37.7 29.9 40.5 41.3 37.5 39.2 0.0061 
Alcohol consumer 
(%) 43.6 59.7 50.9 41.5 32.2 33.2 <0.0001 
Smoker (%) 46.4 45.0 51.1 53.2 41.6 41.2 0.0007 
BMI (kg/m2) 21.94±3.51 21.05±2.70 21.07±2.99 21.78±3.56 22.61±4.08 23.19±3.55 <0.0001 
Systolic BP (mm 
Hg) 145.7±25.0 133.8±20.8 144.4±23.0 148.6±25.8 150.1±26.6 151.6±24.4 <0.0001 
Diastolic BP (mm 
Hg） 83.6±12.7 80.0±12.2 84.1±12.3 84.6±13.4 84.5±13.5 84.8±11.6 <0.0001 
Hypertension (%) 63.50 43.78 62.22 66.33 69.52 75.81 <0.0001 
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Table2: Results from analysis of covariance (ANCOVA) model and logistic regression model on the association between nail selenium level, 
blood pressure measures and  hypertension rate at baseline. 
Note: * ANCOVA model adjusting for age, gender, BMI, education, smoking, and alcohol consumption. 
**Logistic regression model adjusting for age, gender, BMI, education, smoking, and alcohol consumption. 
 
 
Outcome variable 
Quintile groups of selenium level in nail samples (μg/g) 
P Value Q1(n=402) Q2 (n=405) Q3 (n=395) Q4(n=397) Q5(n=401) 
(≤0.233) (0.234-0.362) (0.363-0.442) (0.443-0.552) (>0.552) 
 Parameter Estimates from ANCOVA Models*  
Systolic BP, mm Hg* 0.0(reference) 10.87 (7.58,14.16) 14.45 (11.09,17.81) 15.26 (11.86,18.66) 16.05 (12.65,19.45) <0.0001 
Diastolic BP, mm Hg* 0.0(reference) 3.91 (2.17,5.64) 3.88 (2.10,5.65) 3.48 (1.68,5.27) 3.66 (1.87,5.46) <0.0001 
 Odds Ratios from Logistic Regression Model**  
Hypertension/Normal** 1.0(reference) 2.17(1.63,2.90) 2.46(1.83,3.23) 2.72(2.00,3.70) 3.55(2.59,4.87) <0.0001 
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Table 3: Comparison of baseline characteristics between participants with incident hypertension and those normotensive during follow-up. 
 Overall 
(n=635) 
Normotensive 
(n=275) 
Incident Hypertension 
(n=360) 
P Value 
Nail selenium, (μg/g) 0.367±0.177 0.340±0.188 0.387±0.165 0.0008 
Age (years) 71.1±5.2 71.1±5.3 71.1±5.2 0.8862 
Female (%) 51.97 52.36 51.67 0.8617 
Attended school（%） 35.43 38.18 33.33 0.2056 
Alcohol consumer (%) 44.41 47.27 42.22 0.2044 
Smoker (%) 48.03 48.36 47.78 0.8836 
BMI (kg/m2) 21.05±3.07 20.62±2.71 21.39±3.28 0.0017 
Systolic BP (mm Hg) 123.3±10.3 121.9±10.3 124.4±10.3 0.0018 
Diastolic BP (mm Hg) 74.9±7.8 74.6±7.3 75.2±8.2 0.3209 
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Table 4: Hypertension incidence rate and hazard ratios for incident hypertension by selenium quintile groups during follow-up. 
Selenium quintile groups Incidence rate (%) Hazard ratio(95% CI) P- value 
Q1 (n=192) 45.83 1.0 (reference) -- 
Q2 (n=132) 52.27 1.41(1.03,1.94) 0.0331 
Q3 (n=120) 62.50 1.93(1.40,2.67) <0.0001 
Q4 (n=105) 70.48 2.35(1.69,3.26) <0.0001 
Q5 (n=86) 62.79 1.94(1.36,22.77) 0.0002 
Note: Cox proportional hazards regression model adjusting for age, gender, BMI, education, smoking, alcohol consumption, and physical activity. 
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